Feline Mesenteric Artery Thrombosis (Non-Aortic Thromboembolism)

Feline mesenteric artery thrombosis (non-aortic thromboembolism) is a rare but life-threatening vascular condition in cats in which a thrombus forms within or embolizes to the mesenteric arterial circulation, causing ischemic injury to segments of the small or large intestine. Unlike the more commonly recognized aortic thromboembolism (saddle thrombus), this condition specifically involves branches of the cranial or caudal mesenteric arteries, resulting in intestinal infarction rather than hindlimb paralysis. The condition is most frequently associated with underlying hypercoagulable states, cardiac disease, or neoplasia, and may present insidiously before rapidly progressing to intestinal necrosis and septic peritonitis. Prompt recognition is essential, as delayed diagnosis is associated with a grave outcome.

Underlying predisposing conditions: Feline mesenteric artery thrombosis arises from the same fundamental pathophysiology as other thromboembolic events: disruption of Virchow's triad (endothelial injury, hypercoagulability, and stasis of blood flow). In cats, the most commonly implicated underlying diseases include hypertrophic cardiomyopathy (HCM) and other cardiomyopathies, which promote intracardiac thrombus formation that may embolize to the mesenteric circulation rather than the aortic trifurcation. Additional predisposing conditions include protein-losing nephropathy (PLN), protein-losing enteropathy (PLE), neoplasia (particularly lymphoma and other abdominal malignancies), hyperthyroidism, systemic inflammatory disease, and pancreatitis—all of which can promote hypercoagulable states through loss of antithrombin III, increased procoagulant factor activity, or direct vascular inflammation.

Pathophysiological cascade: Once a thrombus occludes a mesenteric artery branch, the dependent intestinal segment rapidly becomes ischemic. The intestinal wall, particularly the mucosa, is extremely sensitive to oxygen deprivation; ischemic injury begins within minutes to hours. The mucosal barrier breaks down, allowing luminal bacteria and endotoxins to translocate into the portal circulation and peritoneal cavity. Full-thickness intestinal necrosis can develop within 4–6 hours of complete arterial occlusion, leading to septic peritonitis, systemic inflammatory response syndrome (SIRS), and ultimately multi-organ failure if untreated. Reperfusion injury upon restoration of blood flow adds an additional layer of oxidative damage and inflammatory mediator release, further worsening the local and systemic condition. The extent of intestinal injury depends on the size and caliber of the occluded vessel, the presence of collateral circulation, and the duration of ischemia.

Clinical suspicion: Diagnosis begins with a thorough history and physical examination. A cat presenting with acute, severe abdominal pain, cardiovascular instability, and a known underlying disease such as HCM or hyperthyroidism should prompt immediate suspicion of a thromboembolic event affecting the mesenteric vasculature. Abdominal palpation often reveals pain, guarding, and occasionally a doughy or fluid-filled feel consistent with ileus or free peritoneal fluid.

Laboratory findings:

• ·Complete Blood Count (CBC): Leukocytosis with a left shift (elevated band neutrophils, high WBC) is common, reflecting systemic inflammation or early sepsis; thrombocytopenia (low PLT) may be present, suggesting consumptive coagulopathy or disseminated intravascular coagulation (DIC); anemia (low HCT) may develop with hemorrhagic enteropathy
• ·Serum biochemistry: Elevated ALT and liver enzymes may reflect hepatic ischemia; elevated BUN and CREA can indicate prerenal azotemia or concurrent renal disease; hypoalbuminemia (low ALB) may be present if there is protein-losing disease or severe peritoneal exudation; hyperbilirubinemia (elevated TBIL) can occur with hepatic ischemia or hemolysis; electrolyte disturbances (hypokalemia, hypoglycemia) are common in critically ill cats
• ·Coagulation panel: Prolonged PT/aPTT, elevated D-dimers, and reduced antithrombin III levels suggest DIC or a hypercoagulable state
• ·Lactate: Elevated blood lactate is a sensitive marker of intestinal ischemia and tissue hypoperfusion, and a rising lactate despite resuscitation carries a grave prognosis

Diagnostic imaging:

• ·Abdominal ultrasound: The primary non-invasive imaging modality; may reveal absent or markedly reduced Doppler flow in mesenteric vessels, thickened and hypoechoic intestinal walls, loss of normal intestinal wall layering, free peritoneal effusion, and regional ileus; Doppler assessment of the cranial mesenteric artery and its branches is critical
• ·Radiography: May show loss of abdominal detail (free peritoneal fluid), segmental ileus, or gas-pattern abnormalities; less specific than ultrasound
• ·CT angiography (CTA): The gold standard for definitive vascular diagnosis in human medicine and increasingly available in veterinary referral centers; provides excellent visualization of arterial occlusion, extent of intestinal involvement, and collateral circulation; requires anesthesia, which may be prohibitive in critically unstable patients
• ·Abdominocentesis: If free peritoneal fluid is present, sampling and cytological analysis can confirm septic peritonitis (degenerate neutrophils, intracellular bacteria, elevated effusion lactate relative to blood lactate)
• ·Exploratory laparotomy: Often both diagnostic and therapeutic in cats too unstable for prolonged imaging workup; direct visualization of intestinal color, peristalsis, and mesenteric pulsation guides surgical decision-making

Emergency stabilization: All cats with suspected mesenteric artery thrombosis require immediate aggressive supportive care. Intravenous fluid therapy should be initiated promptly to restore circulating volume, though care must be taken in cats with underlying cardiac disease to avoid volume overload. Oxygen supplementation should be provided. Analgesia is essential—opioids such as buprenorphine or hydromorphone are appropriate for pain management without excessive cardiovascular depression.

Anticoagulation therapy:

• ·Unfractionated heparin (UFH) or low-molecular-weight heparin (LMWH, e.g., dalteparin or enoxaparin) should be initiated to prevent thrombus extension and new embolization. LMWH is generally preferred for its more predictable pharmacokinetics in cats
• ·Clopidogrel (antiplatelet therapy): Often used as a long-term adjunct to prevent recurrence, particularly when underlying cardiac disease is the primary etiology
• ·Aspirin: Low-dose aspirin has historically been used but is generally considered less effective and more difficult to dose safely in cats compared to clopidogrel

Thrombolytic therapy: Streptokinase or tissue plasminogen activator (tPA) has been explored in feline thromboembolic disease, but its use in mesenteric thrombosis is high risk due to the potential for hemorrhage into an already compromised intestinal segment and the absence of well-established feline dosing protocols. Thrombolytics are rarely used outside of referral settings with intensive monitoring capability.

Surgical intervention: Surgical exploration is often necessary and is both diagnostic and therapeutic. Surgical goals include:

• ·Resection of necrotic intestinal segments: Any irreversibly ischemic bowel must be resected to prevent ongoing septic peritonitis; end-to-end anastomosis or temporary stoma creation follows resection
• ·Peritoneal lavage: Thorough lavage is performed when septic peritonitis is confirmed
• ·Embolectomy or thrombectomy: Technically challenging in cats given the small caliber of mesenteric vessels; rarely performed but may be considered in early cases at referral centers
• ·"Second-look" laparotomy: Planned 24–48 hours after initial surgery to reassess bowel viability if the extent of ischemia was uncertain at the first operation

Postoperative and supportive care:

• ·Broad-spectrum antibiotics targeting gram-negative and anaerobic bacteria (e.g., ampicillin-sulbactam combined with enrofloxacin or metronidazole) should be initiated as soon as intestinal compromise or peritonitis is suspected
• ·Nutritional support via enteral or parenteral routes should be initiated early
• ·Management of underlying disease (e.g., cardiac medications, thyroid therapy) is essential to reduce recurrence risk
• ·Intensive monitoring of blood pressure, urine output, lactate, and coagulation parameters is required in the perioperative period

Data on long-term prognosis specific to feline mesenteric artery thrombosis (non-aortic) is limited in current veterinary literature; no peer-reviewed survival statistics specifically for this condition were identified in the references cited above. However, based on the known biology of intestinal ischemia and the general veterinary understanding of feline thromboembolic disease, the following clinically grounded observations can be made:

Overall prognosis is grave to poor. The condition carries a high mortality rate, estimated broadly at 70–90%, driven by the combination of rapid progression to intestinal necrosis, the frequency of septic peritonitis at presentation, the risks of anesthesia and surgery in hemodynamically compromised patients, and the recurrence risk associated with underlying conditions such as HCM.

Prognostic factors:

• ·Time to diagnosis and intervention: Cats diagnosed and brought to surgery within the first few hours of arterial occlusion have a better chance of limiting the extent of intestinal necrosis
• ·Extent of ischemic bowel: Involvement of large segments of small intestine (particularly >50–75% of the small intestinal length) is associated with short bowel syndrome or death, even with successful surgery
• ·Presence of septic peritonitis: Confirmed peritonitis at surgery significantly worsens the prognosis
• ·Lactate trends: Persistently elevated or rising blood lactate despite resuscitation is a negative prognostic indicator
• ·Underlying disease severity: Cats with well-controlled underlying disease may have a modestly improved long-term outlook if they survive the acute episode
• ·Hypoalbuminemia (low ALB): Preoperative hypoalbuminemia is associated with poor wound healing and anastomotic failure, increasing perioperative mortality
• ·Thrombocytopenia and DIC: The presence of coagulopathy (low PLT, elevated D-dimers) indicates systemic decompensation and dramatically worsens the prognosis

Even cats that survive the acute surgical episode face a meaningful risk of recurrence if the underlying hypercoagulable condition cannot be definitively controlled.

Management of underlying disease: The most effective preventive strategy is the identification and aggressive management of conditions that predispose cats to thromboembolic events. Regular cardiac screening (echocardiography) in breeds predisposed to HCM (Maine Coon, Ragdoll, British Shorthair, Sphynx) allows early detection of structural heart disease before thrombus formation occurs.

Antiplatelet and anticoagulant prophylaxis:

• ·Clopidogrel is currently the recommended antiplatelet agent for cats with moderate-to-severe HCM and left atrial enlargement, based on evidence that it reduces the risk of thromboembolic events compared to aspirin; while this evidence is primarily derived from studies on aortic thromboembolism, the protective benefit likely extends to other thromboembolic sites
• ·LMWH may be considered for cats at very high risk (e.g., spontaneous echocontrast or an intracardiac thrombus identified on echocardiography)

Monitoring and surveillance:

• ·Cats with protein-losing nephropathy or enteropathy should have antithrombin III levels and coagulation status monitored periodically, with prophylactic anticoagulation considered when antithrombin III is significantly reduced
• ·Cats undergoing treatment for hyperthyroidism should be monitored for cardiac remodeling, as successful treatment can reduce HCM-associated changes and secondary thromboembolic risk
• ·Owners of at-risk cats should be educated to recognize early warning signs (sudden behavioral change, abdominal pain, vomiting) and seek emergency care without delay

No vaccines exist for this condition, as it is a vascular/physiologic disorder rather than an infectious disease.